NeuroOne secures first pharmaceutical industry order for drug delivery platform
NMTC•NeuroOne secured its first pharmaceutical industry purchase order for its StereoCED platform to support a global pharmaceutical company's preclinical research program. A large-animal study is expected to begin early next year.
1. First industry order
NeuroOne secured a purchase order for StereoCED to support a Tier 1 global pharmaceutical company's preclinical research program. The large-animal study is expected to begin early next year and will use the platform's targeted brain drug delivery and neurological monitoring capabilities.
